– CANADA, Toronto – Emblem Corp. (TSXV:EMC | OTCQX:EMMBF), today announced the appointment of Connie A. Stefankiewicz and Loreto Grimaldi to its Board of Directors following Emblem’s annual and special shareholders’ meeting. Harvey Shapiro, current chair, and Maxim Zavet have stepped down from the Board, and the Board would like to thank them for their immense contributions since Emblem’s inception. Ms. Stefankiewicz and Mr. Grimaldi will join current Board members Daniel Milliard, Jeffrey Fineberg, John H. Stewart, Terry Johnson and Nick Dean. In connection with the resignation of Mr. Shapiro, the Board has appointed independent director Mr. Milliard as the new chair of the Board.
“Both Connie and Loreto bring an incredible amount of experience to our Board. Connie possesses an impressive background with a leading Canadian financial institution, most recently serving as Chief Marketing Officer. This expertise will be a valuable asset for Emblem as we pursue our strategic focus on innovation and brand building,” said Nick Dean, CEO of Emblem. “Loreto also brings a strong background as a business partner and trusted advisor to C-suite leaders and boards of directors. As an accomplished senior executive with global legal and business transformation experience, he brings a wealth of knowledge to help inform and shape Emblem’s global growth strategy.”
“With a strategic focus on product innovation, brand building and strengthening its distribution channels, Emblem is at a critical juncture in its evolution,” said Dean. “The Company is poised to see a number of initiatives come to fruition over the coming months, including the opening of a 30,000 sq. ft. Product Innovation Centre with GMP capabilities, entry into the German market in mid-2019, and the continued growth of the both medical and adult-use cannabis markets domestically. The bench strength of the Board will provide the guidance and expertise to see Emblem through this exciting period of growth and transformation.”
Emblem is a fully integrated cannabis company focused on driving shareholder value through product innovation, brand relevance, and access to patient and consumer channels. Through its wholly-owned subsidiary Emblem Cannabis Corporation, Emblem is licensed to cultivate, process, and sell cannabis and cannabis derivatives in Canada under the Cannabis Act. Emblem’s state-of-the-art indoor cannabis cultivation facility and Product Innovation Centre is located in Paris, Ontario. Emblem is also the parent company of GrowWise Health Limited, one of Canada’s leading cannabis education services. Emblem trades under the ticker symbol EMC on the TSX Venture Exchange.
For more information : http://www.emblemcorp.com
- Disclaimer - News, data and statement included in this release are intended exclusively for general information purposes. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of the information. No data or statement in this release should be considered for decisions about securities referred. Product and brand names used in this release maybe trademarks or registered trademarks of their respective owners.
Comments are closed.